申请人:SmithKline Beckman Corporation
公开号:US04588740A1
公开(公告)日:1986-05-13
A series of pharmaceutical compositions which contain 4-aminoalkyl-2(3H)-indolones has been demonstrated to have D.sub.2 -agonist activity useful for treating congestive heart failure and hypertension. A representative ingredient of the compositions is 4-di-n-propylaminoethyl-2(3H)-indolone or a salt thereof.
一系列含有4-氨基烷基-2(3H)-吲哚酮的药物组合物已被证明具有D.sub.2-激动剂活性,可用于治疗充血性心力衰竭和高血压。组合物的代表成分是4-二-n-丙基氨乙基-2(3H)-吲哚酮或其盐。